Management of pseudophakic cystoid macular edema
- 1 March 2015
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 60 (2) , 123-137
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS StudyAmerican Journal of Ophthalmology, 2013
- ANATOMICAL MEASURES AS PREDICTORS OF VISUAL OUTCOMES IN RANIBIZUMAB-TREATED EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2013
- Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular HolesNew England Journal of Medicine, 2012
- Prophylaxis of Pseudophakic Cystoid Macular Edema with Intraoperative PegaptanibJournal of Ocular Pharmacology and Therapeutics, 2011
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Adverse Events After Pars Plana Vitrectomy Among Medicare BeneficiariesArchives of Ophthalmology (1950), 2009
- Incidence of Cystoid Macular Edema after Cataract Surgery in Patients with and without Uveitis Using Optical Coherence TomographyAmerican Journal of Ophthalmology, 2009
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB FOR PSEUDOPHAKIC CYSTOID MACULAR EDEMARetina, 2009
- Anti-vascular endothelial growth factor therapy for ocular neovascular diseaseCurrent Opinion in Ophthalmology, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006